Brief: Calidi Bio: To Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform at Conference
12/02/2024 12:09
Feb 12 (Reuters) - Calidi Biotherapeutics Inc CLDI.A :
* CALIDI BIOTHERAPEUTICS TO HIGHLIGHT NOVEL SYSTEMIC
ENVELOPED
ONCOLYTIC VIROTHERAPY PLATFORM DESIGNED TO TARGET ALL TUMOR
SITES AT UPCOMING CONFERENCE
Source text for Eikon: ID:nBw8sYTKSa
Further company coverage: CLDI.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma